This article is mentioned in:

Introduction

Obstructive jaundice (OJ) occurs due to occlusion of the common bile duct, or complications associated with surgery, tumor, trauma, gallstones, hepatitis, or idiopathic and metabolic diseases, including primary biliary cirrhosis and sclerosing cholangitis (1). Cholestatic liver injury is accompanied by serious complications, which increase the risk of mortality and morbidity (2). The mechanisms by which cholestasis induce acute liver injury remain controversial; however, intrahepatic accumulation of reactive oxygen species (ROS) is thought to be an important contributory factor (3–5). ROS are able to trigger the opening of mitochondrial permeability transition (MPT) pores in the mitochondrial inner membrane, which nonspecifically transport solutes up to a molecular mass of 1,500 Da (6). Opening of MPT pores lead to cytochrome c release and apoptosis (7,8). Previous studies have indicated that mitochondrial stress and apoptosis have an important role in hepatic injury in OJ (8,9). In particular, it has been demonstrated that, following cholestasis, an accumulation of bile acids in hepatocytes contributes to cell death and is one of the major pathogenic factors resulting in chronic liver damage and fibrosis (10).

Hydrogen (H2), in the gaseous state or dissolved in water, has been reported to have therapeutic value as a selective antioxidant via its ability to reduce cytotoxic ROS and to suppress inflammatory reactions (11–13). Unlike other gaseous molecules, H2 can penetrate the cell membrane to reach subcellular compartments, including mitochondria, which are notoriously difficult to target. The utilization of H2 gas-saturated physiological saline, also known as hydrogen-rich saline (HS), is considered to be less complicated and safer than H2 gas inhalation for clinical application. Furthermore, we have previously demonstrated that HS is able to attenuate bile duct ligation (BDL)-induced liver damage by reducing hepatic oxidative stress and inflammation, and can reduce apoptosis in neonatal brain tissue from a rat model of hypoxia-ischemia (14,15). The present study specifically assessed the impact of BDL-induced injury on the hepatic mitochondria of mice, in order to investigate whether HS was able to exert direct protective effects on the mitochondria, and thus prevent mitochondrial damage and mitochondria-induced hepatocyte apoptosis.

Materials and methods

HS production

HS was prepared as previously described (16). HS was freshly prepared on a weekly basis to ensure that a concentration >0.6 mmol/l was maintained.

Experimental protocol

Male C57BL/6 mice, weighing 22–25 g, were obtained from the Experimental Animal Center of Chinese Academy of Sciences (Shanghai, China). Mice received ad libitum access to standard rodent chow and tap water, and were maintained under a natural day/night cycle. All experimental procedures were approved by the Institutional Animal Care and Use Committee of Nankai University (Tianjin, China).

Mice were randomly divided into three experimental groups, each containing 20 mice. Group 1 animals underwent a sham operation and were treated with normal saline (NS; 10 ml/kg); group 2 animals underwent BDL and were treated with NS (10 ml/kg); and group 3 animals underwent BDL and were treated with HS (10 ml/kg).

Prior to the operation, mice were fasted for 12 h with ad libitum access to water. Each mouse was weighed and anesthetized with pentobarbital (50 mg/kg; i.p.; Shanghai Reagent Factory, Shanghai, China). Following a midline incision, the common bile duct was exposed and a double-ligature was performed using 6-0 silk suture, causing the bile duct to be sectioned between the ligatures. In sham-operated animals, the common bile duct was freed from the surrounding soft tissue without ligation. A running suture was used for abdominal closure using 2-0 nylon. NS or HS was administered intraperitoneally at 14:00 every day, beginning 2 h prior to the operation and continuing until 2 days after. Mice were sacrificed via cervical dislocation according to protocol 3 days after BDL.

Preparation of mitochondrial and cytosolic fractions

Following homogenization of the liver tissues, liver mitochondria and cytosol were prepared by differential centrifugation using a mitochondria isolation kit (Pierce Biotechnology, Inc., Rockford, IL, USA), according to manufacturer's protocol. The resulting supernatant contained soluble mitochondrial protein, which was used for western blot analysis of B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and mitochondrial cytochrome c. Protein content was determined using a bicinchoninic acid (BCA) protein assay kit (Pierce Biotechnology, Inc.).

Determination of antioxidant and lipid peroxidation levels in mitochondria

The mitochondrial suspension was acidified with 2% 3-[(3-cholamidopropyl)dimethylammonio]-1-pro-panesulfonate in Tris-buffered saline (TBS) and centrifuged at 9,055.8 × g for 2 min at room temperature, according to manufacturer's protocol for the mitochondria isolation kit. The supernatant was analyzed for mitochondrial malondialdehyde (mMDA), mitochondrial glutathione (mGSH), mitochondrial glutathione disulfide (mGSSG), mitochondrial superoxide dismutase (mSOD), mitochondrial catalase (mCAT), and mitochondrial glutathione peroxidase (mGpx) levels. mMDA levels, and reduced and oxidized mGSH levels were assessed spectrophotometrically, according to previously described methods (16,17). mSOD, mCAT and mGpx activities were assessed using commercial enzyme-linked immunosorbent assay kits, according to the manufacturer's protocols (Nanjing Jiangcheng Bioengineering Institute, Nanjing, China). All readings were taken using a spectrophotometer (Synergy 2; BioTek Instruments, Inc., Winooski, VT, USA). All assays were conducted in duplicate. Protein content in each sample was determined using a BCA protein assay kit (Pierce Biotechnology, Inc.).

Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining

Following dehydration, permeation and methanol fixation, TUNEL staining was performed on 5-μm-thick paraffin-embedded sections using an In Situ Cell Death Detection kit (Nanjing Keygen Biotech. Co. Ltd., Nanjing, China), according to manufacturer's protocol, in order to detect apoptotic hepatocytes. TUNEL-positive cells were detected using an Olympus IX70 fluorescence microscope (Olympus Corporation, Tokyo, Japan).

Fluorescence-activated cell sorting (FACS) analysis

Single-cell suspensions were prepared using a Tissue Dissociation kit (Nanjing Keygen Biotech. Co. Ltd.), according to the manufacturer's protocol. Hepatocyte apoptosis was measured by flow cytometric analysis using an Annexin V-fluorescein isothiocyanate (FITC) assay (Nanjing Keygen Biotech. Co. Ltd.), according to the manufacturer's protocol. Hepatocytes were stained with Annexin V and propidium iodide (PI; BD Biosciences, San Diego, CA, USA) (18) and apoptotic cells were identified as Annexin V-positive/PI-negative. Analysis was performed using the BD FACSAria flow cytometer (BD Biosciences).

Caspase activity assay

Caspase 3, 8 and 9 activities were measured in liver tissue using Caspase Assay kits (Promega Corporation, Madison, WI, USA), according to the manufacturer's protocols. The luminescence of each sample was measured using a spectrophotometer (Synergy 2; BioTek Instruments, Inc.).

Mitochondrial swelling

Fresh liver mitochondria were isolated from the BDL and sham-operated mice by differential centrifugation and incubated with 100 μM CaCl2 prior to treatment with cyclosporin A (CsA, 1 mM; Amresco, LLC, Solon, OH, USA) MPT inhibitor to assess calcium-induced mitochondrial swelling, as previously described (19).

Western blot analysis

Mitochondrial lysates were used for western blot analysis of cytochrome c, Bcl-2 and Bax. Cytosolic fractions were used for western blot analysis of cytochrome c, and were processed according to the manufacturer's protocol (Abcam, Cambridge, MA, USA). Proteins (2.5 μg/μl) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto a polyvinylidene difluoride membrane (Bio-Rad Laboratories, Hercules, CA, USA). Following blocking with 5% skimmed milk, the membranes were washed three times in TBS with Tween 20 (TBST) for 5 min, and subsequently incubated with primary monoclonal antibodies against cytochrome c (ab13575), Bcl-2 (ab32503) and Bax (all 1:1,000; ab117115) for 2 h at room temperature. Following washing three times with TBST for 5 min, the membranes were subsequently incubated with goat anti-mouse and rabbit secondary antibodies (1:2,000; DC02L-200UG; Calbiochem, LaJolla, CA, USA) for 2 h at room temperature. For all determinations, mouse monoclonal anti-glyceraldehyde 3-phosphate dehydrogenase antibody (1:5,000; ab9485; Abcam)) was used as a loading control and goat anti-manganese superoxide dismutase antibody (1:1,000; 13194; Cell Signaling Technology, Inc., Danvers, MA, USA) was used as a mitochondrial loading control. Blots were visualized using a Beyotime enhanced chemiluminescence Plus substrate system (Beyotime Institute of Biotechnology, Haimen, China) and analyzed with Quantity One 4.62 software (Bio-Rad Laboratories). It should be noted that it has previously been suggested that cytoplasmic cytochrome c may exist in polymeric forms, appearing as a 58–60 kD protein-sized band in western blots, rather than in monomeric form, which migrates at a reduced molecular weight of 15 kD (20).

Transmission electron microscopy (TEM)

Liver samples were fixed in a 2% solution of glutaraldehyde and post-fixed in osmium tetroxide, prior to embedding in epoxy resin for TEM. Ultrathin sections (40–50 nm) were stained with uranyl acetate and lead citrate, and were then examined under a TEM (Hitachi H-7650; Hitachi, Tokyo, Japan).

Determination of mitochondrial adenosine triphosphate (ATP) content

ATP content was measured using the ATP Bioluminescent Assay kit (Sigma-Aldrich Canada, Oakville, ON, Canada), according to the manufacturer's protocol.

Determination of mitochondrial respiratory function

Mitochondrial respiratory function was determined using the Clark Oxygen Electrode system (Oxygraph™, Hansatech Instruments, Ltd., King's Lynn, UK), according to previously described methods (21). The mitochondrial respiratory control ratio (RCR) and adenosine diphosphate (ADP) to oxygen ratio (ADP/O) can reflect mitochondrial respiratory function and integrity of the respiratory chain. Mitochondrial RCR is the ratio of state 3 and 4 respiration rates. ADP/O is the ratio of ADP and state 3 oxygen consumption. State 3 is the respiration rate after the addition of 1 mM ADP; whereas state 4 is the oxygen consumption rate after the complete phosphorylation of ADP.

Statistical analysis

All experiments were performed in triplicate and statistical analyses were conducted using SPSS 22.0 software (IBM SPSS, Armonk, NY, USA). Data are presented as the mean ± standard deviation. Statistical analyses were performed using one-way analysis of variance (ANOVA) for the comparison of three groups. When ANOVA exhibited significant differences, pairwise comparisons between means were tested by Student-Newman-Keuls post-hoc test. P<0.05 was considered to indicate a statistically significant difference.

Results

HS prevents mitochondrial oxidative stress and increases antioxidant activities in BDL mice

The levels of mMDA were significantly increased (99.6%) in the livers of BDL mice compared with in the sham-operated mice. Conversely, treatment with HS markedly prevented the elevation of lipid peroxidation in mitochondria (Fig. 1A; P=0.006). The potential antioxidative properties of HS were determined by measuring the levels of mGSH and mGSSG. In NS-treated BDL mice, mGSH levels were reduced to 58.9% of normal levels and mGSSG levels were increased by 1.276-fold; however, HS significantly attenuated the altered mGSH and mGSSG levels (Fig. 1B and C; P=0.005 and P=0.004, respectively). The results also indicated that an increase in mitochondrial oxidative stress was accompanied by a significant decrease in the activities of the antioxidant enzymes SOD, CAT and Gpx in the hepatic mitochondria of BDL mice, whereas HS treatment markedly increased antioxidant activities in BDL mice (Fig. 1D–F; P=0.006, P=0.005 and P=0.009, respectively).

Figure 1 Effects of HS on liver mitochondrial enzyme levels and activities following BDL in mice. (A) Mitochondrial MDA levels; (B) mitochondrial GSH levels; (C) mitochondrial GSSG levels; (D) mitochondrial SOD activities; (E) mitochondrial CAT activities and (F) mitochondrial Gpx activities were measured spectrophotometrically, according to the manufacturers' protocols. Data are presented as the mean ± standard deviation. **P<0.01 vs. the BDL + NS group. HS, hydrogen-rich saline; BDL, bile duct ligation; NS, normal saline; MDA, malondialdehyde; GSH, glutathione; GSSG, glutathione disulfide; SOD, superoxide dismutase; CAT, catalase; Gpx, glutathione peroxidase.

HS decreases apoptosis in hepatocytes from BDL mice

HS markedly reduced the number of TUNEL-positive cells in the liver compared with the NS-treated group (Fig. 2A), thus suggesting that HS is able to inhibit BDL-induced hepatocyte apoptosis. To further confirm that HS affected hepatocyte apoptosis, flow cytometric analysis was conducted using Annexin V-FITC and PI staining, in order to discriminate between apoptotic and necrotic cells. In BDL mice, treatment with HS induced significantly lower levels of apoptosis (39.8%) compared with in the NS-treated group (52.5%) (Fig. 2B and C; both P=0.008).

Figure 2 HS treatment decreases hepatocyte apoptosis in BDL mice. (A) Liver samples were sectioned and stained with TUNEL. Notably, HS markedly reduced the number of TUNEL-positive cells in HS-treated livers compared with NS-treated livers (magnification, 100×). Arrows indicate TUNEL-positive cells. (B) Apoptosis was assessed by flow cytometric analysis after the hepatocytes were stained with Annexin V-FITC/PI. (C) Quantitative analysis of the percentage of apoptotic cells. Data of three replicates are presented as the mean ± standard deviation. **P<0.01 vs. the BDL + NS group. (D) Caspase 3, 8 and 9 activities were measured by colorimetric assays with a spectrophotometer. Data are presented as the mean ± standard deviation. HS, hydrogen-rich saline; BDL, bile duct ligation; NS, normal saline; TUNEL, Terminal deoxynucleotidyl transferase dUTP nick end labeling; FITC, fluorescein isothiocyanate; PI, propidium iodide.

HS inhibits caspase activities in the livers of BDL mice

Since caspase activation has a key role in apoptotic cell death, the present study further investigated whether caspase activities could be altered following treatment with HS. BDL triggered a significant increase in hepatic caspase 3, 8 and 9 activities, whereas HS administration significantly reduced caspase activities (Fig. 2D; P=0.007, P=0.008 and 0.007, respectively). These findings were consistent with the results of the apoptosis analysis.

HS inhibits mitochondrial swelling

Mitochondria from the sham-operated mice tolerated Ca2+ at a concentration of 100 μM without undergoing MPT, as assessed by a mitochondrial swelling assay (22). Conversely, mitochondria from the NS-treated BDL mice were much more sensitive to MPT induction. A large-amplitude swelling was observed in mitochondria isolated from NS-treated BDL mice compared with in the mitochondria from sham-operated mice. In addition, treatment with HS prevented BDL-induced mitochondrial swelling (Fig. 3).

Figure 3 Mitochondrial swelling in the liver of BDL mice. Mitochondrial swelling was monitored by decreases in absorbance at 540 nm following the addition of 100 μM CaCl2. The dotted lines indicate the incubation of mitochondria from BDL mice treated with NS, HS or CsA. The results are representative of four experiments. HS, hydrogen-rich saline; BDL, bile duct ligation; NS, normal saline; CsA, cyclosporin A.

HS inhibits mitochondrial cytochrome c release in the liver of BDL mice

Western blot analysis (Fig. 4) indicated that NS-treated BDL mice exhibited a significant reduction in the protein expression levels of mitochondrial cytochrome c, which was accompanied by a release into the cytoplasm, as reflected by an increase in cytosolic cytochrome c expression levels (Fig. 4A and C; P=0.008). Treatment with HS significantly inhibited the release of cytochrome c from the mitochondria to the cytoplasm (Fig. 4A and C; P=0.006).

Figure 4 Western blot analysis of cytochrome c, Bcl-2 and Bax protein expression levels in BDL mice. (A) Mitochondrial and cytosolic lysates were subjected to western blotting using cytochrome c-specific antibodies. Treatment with HS significantly suppressed the release of cytochrome c from the mitochondria into the cytosol. Images are representative of four independent experiments. SOD2 and GAPDH were used as the mitochondrial and cytosolic loading controls, respectively. (B) Liver lysates were subjected to western blot analysis using Bcl-2 and Bax-specific antibodies. The protein expression levels of Bax were increased, whereas Bcl-2 expression was decreased in livers from HS-treated mice compared with those obtained from NS-treated mice. Images are representative of four independent experiments. GAPDH was used as a loading control for normalization. (C and D) Western blotting quantification. Data are presented as the mean ± standard deviation. **P<0.01 vs. the BDL + NS group. HS, hydrogen-rich saline; BDL, bile duct ligation; NS, normal saline; SOD2, manganese superoxide dismutase; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein.

HS prevents alterations in mitochondrial Bcl-2 family protein expression in the liver of BDL mice

Pro-apoptotic and anti-apoptotic members of the Bcl-2 protein family have critical roles in regulating the MPT and cytochrome c release (23). Therefore, the present study evaluated the mitochondrial expression levels of Bcl-2 and Bax in BDL livers. Western blotting demonstrated a significant increase in Bax protein expression, and a concomitant reduction in Bcl-2 protein expression in the mitochondria of BDL mice (Fig. 4B and D; P=0.006). These BDL-induced effects were prevented by HS treatment (Fig. 4B and D; P=0.008).

HS protects mitochondrial ultrastructure in BDL mice

TEM analysis of liver tissue indicated that mitochondrial ultrastructural alterations occurred in the hepatocytes of NS-treated BDL mice in the present study. In addition to the observed swelling, TEM analysis clearly showed impaired mitochondria, with an absent double membrane; distorted cristae, which were far fewer than in the sham mice; and an appreciable reduction in electron-dense granules in the intramitochondrial matrix. All of these ultrastructural modifications were markedly alleviated following treatment with HS (Fig. 5).

Figure 5 Ultrastructural analysis of hepatocyte mitochondria using TEM. In addition to the observed swelling, TEM studies clearly indicated impaired mitochondria, with an absent double membrane; distorted cristae, which were far fewer than in controls; and an appreciable reduction in electron-dense granules in the intramitochondrial matrix. All of these ultrastructural modifications were markedly alleviated following treatment with HS. Arrows indicate mitochondria. TEM, transmission electron microscopy; BDL, bile duct ligation; NS, normal saline; HS, hydrogen-rich saline.

HS prevents the depletion of ATP levels in hepatocytes of BDL mice

The present study examined the effects of HS on ATP levels, which is a sensitive parameter of mitochondrial function. ATP levels were decreased (67.1%) in BDL mice compared with in the sham-operated mice. Conversely, treatment with HS significantly increased ATP levels in the hepatocytes of BDL mice (Fig. 6; P=0.007).

Figure 6 ATP levels in the hepatocytes of BDL mice. ATP content was measured in isolated mitochondria using a luciferase-based assay. Data are presented as the mean ± standard deviation. **P<0.01, vs. the BDL group. ATP, adenosine triphosphate; HS, hydrogen-rich saline; BDL, bile duct ligation.

HS improves the BDL-induced decline in mitochondrial respiratory function

BDL induced a significant reduction in RCR (31.3%) compared with in the sham-operated mice (P<0.01). This decrease in RCR could be principally attributed to the observed significant decrease (18.5%) of State 3 (Fig. 7A; P=0.009), as opposed to the 19.3% increase of State 4 (Fig. 7B; P= 0.009). HS promoted a significant increase in RCR compared with the NS group (Fig. 7C; P=0.08). This protection was principally related to an increase of State 3 and a decrease of State 4 (Fig. 7A and B). ADP/O was also significantly increased (17.4%) following HS treatment (Fig. 7D; P=0.009).

Figure 7 Phosphorylation (State 3) and resting (State 4) respiratory rates in liver mitochondria isolated from sham-operated and BDL mice, treated with NS or HS. (A) State 3 respiration rates. (B) State 4 respiration rates. (C) Mitochondrial RCR and (D) ADP/O ratios. Results are presented as the mean ± standard deviation (n=20). State 3 and State 4 respiration rates are expressed as nM oxygen/min/mg protein. The mitochondrial RCR is a ratio of state 3 and state 4. **P<0.01 vs. the BDL + NS group. HS, hydrogen-rich saline; BDL, bile duct ligation; NS, normal saline; RCR, respiratory control ratio; ADP/O, adenosine diphosphate to oxygen.

Discussion

OJ induces ROS generation and tumor necrosis factor-α expression in the liver, both of which can induce depolarization of the mitochondrial membrane and eventually initiate apoptosis (24). Our previous study demonstrated that HS was able to ameliorate BDL-induced liver injury by reducing oxidative stress and inflammatory cascades in liver tissue (14). Theoretically, H2 is highly diffusible and could potentially reach mitochondria, which are targets of excessive ROS and central mediators of apoptosis (25,26). Therefore, the aim of the present study was to evaluate whether HS, a selective antioxidant, has the capacity to reduce mitochondrial oxidative stress, and thus protect against mitochondrial dysfunction and inhibit mitochondrial apoptosis, in order to prevent BDL-induced liver injury.

Mitochondria are the major source and target of excessive ROS (26). Mitochondrial GSH scavenges free oxygen radicals that are generated by the mitochondrial respiratory chain (27) and antioxidant enzymes, including SOD, CAT and Gpx, work synergistically to cope with oxidative stress. Accumulated exposure to ROS leads to an oxidative stress burden in the mitochondria, which can induce an apparent increase in ROS generation by the electron transfer chain and suppress the mitochondrial antioxidant system (28). In the present study, mMDA was significantly increased by BDL. In addition, OJ was revealed to impair the activities of mSOD, mCAT and mGpx by 36.1, 53.8 and 32.2%, respectively, and mGSH was also depleted by BDL-induced oxidative stress. Treatment with HS markedly decreased mMDA levels, increased mGSH levels, and elevated the activities of mSOD, mCAT and mGpx, thus suggesting that H2 may reduce mitochondrial lipid peroxidation, boost antioxidant capacity and maintain the mitochondrial redox balance.

Mitochondrial oxidative stress triggers the opening of the MPT pore, and the simultaneous collapse of the mitochondrial membrane potential (MMP) (29–31). MPT further increases the permeability of the mitochondrial outer membrane and induces mitochondrial swelling (30,31). Furthermore, cytochrome c, a mitochondrial intermembrane protein, is released into the cytosol via specific channels, including the MPT pore and Bax channel, and may further activate the downstream caspase pathway to induce irreversible apoptosis (31).

The present study used 100 μM CaCl2 as an MPT inducer, and demonstrated that HS-treated BDL mice exhibited a decrease in mitochondrial swelling compared with the NS-treated mice, thus indicating that HS inhibits the opening of the MPT pore and prevents the onset of MPT. Similar results were obtained following an intraperitoneal injection of CsA for MPT protection. CsA, which is a specific MPT inhibitor, was able to significantly protect against BDL-induced mitochondrial swelling. The combination of CsA and HS offered more efficient protection than HS or CsA alone against BDL-induced mitochondrial swelling. Therefore, it may be hypothesized that part of the mechanism involved in HS-induced protection is via inhibition of MPT. The present study also detected leakage of cytochrome c into the cytosol in BDL mice, which is correlated with MPT pore opening. Conversely, treatment with HS prevented the release of cytochrome c into the cytosol.

Mitochondria are the central control point of apoptosis (32). OJ induces apoptotic cell death, which is associated with mitochondrial oxidative stress, MMP alteration and cytochrome c release (33,34). In the present study, BDL resulted in the accumulation of TUNEL-positive and Annexin-V-positive cells. The TUNEL-positive and Annexin-V-positive cells were markedly decreased in the HS-treated group, thus suggesting that HS may provide hepatic protection via its anti-apoptotic activity.

Members of the Bcl-2 family are key players in the mitochondrial intrinsic pathway of apoptosis (35). The Bcl-2 family consists of pro- and anti-apoptotic proteins that work together to mediate mitochondrial integrity and maintain a dynamic balance between cell survival and cell death. Bax integrates with the permeability transition pore complex and forms specific proteolipid channels in the outer membrane, in order to promote cytochrome c release, whereas Bcl-2 directly binds to Bax to inhibit formation of the proteolipid pore (36–38). In the present study, BDL increased the expression of Bax and decreased the expression of Bcl-2 in the liver, whereas treatment with HS markedly attenuated BDL-induced elevation of Bax expression and reduction of Bcl-2 expression. These data suggested that HS may markedly suppress downstream apoptotic events by modulating the expression levels of Bcl-2 family members.

The caspase family consists of cysteine proteases that can cleave target proteins at specific aspartate residues. Previous studies have reported that caspases have important roles in the initiation, regulation and execution of apoptosis of hepatocytes in response to BDL-induced injury (38–40). One of the main consequences following mitochondrial cytochrome c release is the activation of caspase 3 through the apoptosome, which consists of cytochrome c, apoptotic protease activating factor-1 and procaspase 9 (9). Caspases 3 and 9 are downstream effectors in the caspase-dependent intrinsic apoptosis pathway, whereas caspase 8 is an essential part of the extrinsic pathway. The present study demonstrated that activation of caspases 3, 8 and 9 was significantly suppressed in HS-treated mice, thus indicating that HS may inhibit BDL-induced apoptosis via both intrinsic and extrinsic pathways.

The results of the present study demonstrated that HS was able to protect mitochondrial respiratory function and attenuate the depletion of mitochondrial ATP in BDL mice. In addition, HS was shown to attenuate mitochondrial ultra-structural injury, as evidenced by TEM observations. These results strongly suggested that HS may effectively prevent BDL-induced mitochondrial dysfunction.

In conclusion, the present study provides some of the first evidence to suggest that HS is able to ameliorate BDL-induced acute liver damage by reducing mitochondrial ROS production, protecting against mitochondrial dysfunction, and inhibiting mitochondria-mediated apoptosis. These findings provide evidence regarding the possible mechanisms underlying the protective role of HS. Furthermore, H2 treatment appears to decrease liver fibrosis, cirrhosis, and overall mortality during long-term cholestasis (unpublished data). Since mitochondria are known to be involved in numerous signaling pathways and there are limited data from clinical trials involving HS treatment, it remains to be elucidated whether the regulatory effects of HS on gene pathways associated with apoptosis and oxidative stress have direct clinical value.

Abbreviations:

Acknowledgments

The present study was supported by a grant from the National Natural Science Foundation of China (grant no. 31170926).

References